Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Hematology & Oncology Physician in Los Angeles, CA
NPI: 1023243748Primary Employer
USC Care Medical Group, Inc
keckmedicine.org
HQ Phone
Get M.D. Danielle's Phone Numberphone_androidMobile
Get M.D. Danielle's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
2021 - 2025
IL State Medical License
2012 - 2023
IN State Medical License
2015 - 2017
CA State Medical License
IL State Medical License
American Board of Internal Medicine
Hematology
American Board of Internal Medicine
Medical Oncology
Loyola University Medical Center
Fellowship • Hematology and Medical Oncology
2012 - 2015
McGaw Medical Center of Northwestern University
Residency • Internal Medicine
2009 - 2012
University of Arkansas For Medical Sciences College of Medicine
Medical School
Until 2009
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 276 | 759 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 115 | 275 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 33 | 33 |
| 4 | 99213Established patient office or other outpatient visit, typically 15 minutes | 30 | 51 |
| 5 | 99223Initial hospital inpatient care, typically 70 minutes per day | 29 | 29 |
Authors: Andrew Evens, Leo Gordon, Leo Gordon
Journal: Curr Oncol Rep
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: NRG Oncology
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, PROCEDURE: Biospecimen Collection, DRUG: Topotecan Hydrochloride, DRUG: Olaparib, DRUG: Paclitaxel, PROCEDURE: Computed Tomography with Contrast, PROCEDURE: Computed Tomography, BIOLOGICAL: Durvalumab, PROCEDURE: Multigated Acquisition Scan, DRUG: Pegylated Liposomal Doxorubicin Hydrochloride, PROCEDURE: Echocardiography Test, DRUG: Cediranib Maleate
Lead Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Questionnaire Administration, OTHER: Quality-of-Life Assessment, OTHER: Best Practice, OTHER: Educational Intervention, BEHAVIORAL: Motivational Interviewing, OTHER: Text Message-based Navigation Intervention
Lead Sponsor: GlaxoSmithKline
Intervention / Treatment: DRUG: Niraparib